Patents by Inventor Jeffrey Enders

Jeffrey Enders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NORMALIZING MEASURED DRUG CONCENTRATIONS IN ORAL FLUIDS AND TESTING FOR POTENTIAL NON-COMPLIANCE WITH DRUG TREATMENT REGIMEN
    Publication number: 20180045744
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In an embodiment, the method comprises measuring a drug level in oral fluid of a subject and normalizing the measured drug level as a function of one or more parameters associated with the subject. Embodiments of the methods Use patient derived parameters together with the prescribed dose to affect a transformed and normalized value that can be compared to a transformed and normalized standard distribution derived from a body of collected oral fluid test results.
    Type: Application
    Filed: January 15, 2016
    Publication date: February 15, 2018
    Inventors: Gregory L. Mcintire, Ayodele Morris, Oneka Cummings, Jeffrey Enders
  • METHODS OF MONITORING FOR ADHERENCE TO BREXPIPRAZOLE (REXULTI®) THERAPY
    Publication number: 20170276692
    Abstract: Methods for helping to monitor subject adherence with a prescribed antipsychotic drug treatment regimen are disclosed.
    Type: Application
    Filed: March 24, 2017
    Publication date: September 28, 2017
    Inventors: Gregory L. McIntire, Jeffrey Enders, Erin Strickland
  • METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY
    Publication number: 20170192025
    Abstract: The present disclosure provides methods for monitoring subject (e.g., patient) adherence to lurasidone therapy, for example as a component of treating a subject for a mental health disorder such as schizophrenia.
    Type: Application
    Filed: March 24, 2017
    Publication date: July 6, 2017
    Inventors: Jeffrey Enders, Erin Strickland, Gregory L. McIntire, Ayodele Morris
  • Methods of monitoring adherence to lurasidone therapy
    Patent number: 9606132
    Abstract: The present disclosure provides methods for monitoring subject (e.g., patient) adherence to lurasidone therapy, for example as a component of treating a subject for a mental health disorder such as schizophrenia.
    Type: Grant
    Filed: December 11, 2014
    Date of Patent: March 28, 2017
    Assignee: AMERITOX, LTD.
    Inventors: Jeffrey Enders, Erin Strickland, Gregory L. McIntire, Ayodele Morris
  • METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY
    Publication number: 20150168431
    Abstract: The present disclosure provides methods for monitoring subject (e.g., patient) adherence to lurasidone therapy, for example as a component of treating a subject for a mental health disorder such as schizophrenia.
    Type: Application
    Filed: December 11, 2014
    Publication date: June 18, 2015
    Inventors: Jeffrey Enders, Erin Strickland, Gregory L. McIntire, Ayodele Morris